3.86% -0.19

Rocket Pharmaceuticals Inc (RCKT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	15.86% 43.96	52.25	71.15	64.39	69.42
Interest Income/Expense	0.00% 0.473	0.473	0.473	0.472	0.471
Operating Income/Loss	15.86% -43.96	-52.25	-71.15	-64.39	-69.42
Income/Loss From Continuing Operations Before Tax	15.49% -42.54	-50.33	-68.92	-61.33	-66.72
Income/Loss From Continuing Operations After Tax	15.49% -42.54	-50.33	-68.92	-61.33	-66.72
Net Income/Loss	15.49% -42.54	-50.33	-68.92	-61.33	-66.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.80% 0.2236	111.57	111.02	110.09	94.16
Diluted Average Shares	99.80% 0.2236	111.57	111.02	110.09	94.16
Basic Earnings Per Share	15.56% -0.38	-0.45	-0.62	-0.56	-0.71
Diluted Earnings Per Share	15.56% -0.38	-0.45	-0.62	-0.56	-0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%